Studies

Thankfully there is much important research published already with the aim of increasing occupational safety and protecting caregivers from hazardous medicinal products.

Should you like to add another independent study to below, please let us know.

​

https://www.theparliamentmagazine.eu/news/article/preventing-the-exposure-of-nurses-and-health-professionals-to-hazardous-drugs

 

https://cytoprevent.eu/2021/01/25/eu-policy-recommendations-preventing-occupational-exposure-to-cytotoxic-and-other-hazardous-drugs/

 

​

Hazardous Drug and Waste Clinical Guidance 2018 to 2023

Here are the most recent guidance from the EU Commission and NHS, HSE and the US on the safe management of hazardous drugs and waste:

 

European Commission Guidance for the Safe Management of Hazardous Medicinal Products 2023

 

ETUI – European Trade Union Institute - list of hazardous medicinal products (HMPs) including cytotoxics and based on the EU CLP classification system of Carcinogenic, Mutagenic and Reprotoxic (CMR) substances – free PDF download: 

 

Guidance on Handling of Injectable Cytotoxic Drugs in Clinical Areas in in NHS Hospitals in the UK (Yellow Cover) Edition 1 July 2018

​

USP 800 Mandatory Guidance for Handling Hazardous Drugs to minimize the risk of exposure to healthcare personnel, patients and the environment – USA All States 

​

 

Health and Safety Executive UK 

​

Safe handling of cytotoxic drugs in the workplace

​

EU: Policy Recommendations – Preventing occupational exposure to cytotoxic and other hazardous drugs | CytoPrevent

​

https://www.usp.org/sites/default/files/usp/document/our-work/healthcare-quality-safety/800-know-your-exposure-to-hazardous-drugs.pdf

​